drugset / Trial / NCT02120339
Carvedilol PAH A Pilot Study of Efficacy and Safety
NaSingle-groupOpen-labelBasic science
Summary
Estimate the effect of chronic beta-adrenergic receptor blockade with carvedilol on RV function in patients with PAH. Assess the safety and tolerability of chronic carvedilol therapy in patients with PAH
Timeline
- Start
- 2014-05
- Primary completion
- 2015-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carvedilol | Other / unclassified | 6.25 mg | — |